Donald McNutt, Dennis Fenton, Fabrizio Bonanni, Madhu Balachandran, Stephanie Jenks, Dawn Freeman, Sandra Fujiyama, Trevor Chaplick, Michael Prakken

 

Donald McNutt has been named executive vice president-operations by Health Care Property Investors, the real estate investment trust based in Long Beach, Calif. He joined the firm Aug. 1.

 

Previously McNutt was treasurer and senior vice president of capital markets for The Irvine Company, a privately-held real estate investment company whose portfolio includes office buildings, hotels, apartment communities and retail centers. Prior During his 31-year tenure with Irvine, McNutt has held responsibility for operations, development and leasing, including leasing activities for the company's 24 million square foot portfolio of office properties.

 

As of June 30, HCP’s portfolio included 675 properties and consisted of 323 senior housing facilities, 216 medical office buildings, 41 hospitals, 66 skilled nursing facilities and 29 other healthcare facilities.

 

 

 

Dennis Fenton, Amgen’s executive vice president of operations and one of the company’s longest-tenured staffers, will retire at the end of this year, the company announced Aug. 1.

 

Fenton, 55, is a research scientist by training who led virtually every segment of Amgen over his 25 years with the company, including research, process development, sales and marketing, engineering and manufacturing.

 

"Dennis will be deeply missed by all of us who have had the pleasure to work with him over the years. He has been one of the greatest champions of the Amgen values and a true ambassador of our heritage," said Amgen Chairman and CEO Kevin Sharer in a company press release announcing Fenton’s retirement. "As head of Operations, Dennis helped build the most reliable, efficient and skilled biotechnology manufacturing operation in the world. For that achievement, among many others, we are eternally grateful."

 

Fabrizio Bonanni has been named to succeed Fenton as head of operations, effective immediately. He has overseen the company's site operations and contract manufacturing as senior vice president of manufacturing since March 2003. Previously, he was Amgen's senior vice president for quality and compliance, and a corporate compliance officer. Before joining Amgen, Bonanni was corporate vice president for regulatory and clinical affairs, and corporate vice president of quality systems for Baxter International.

 

Succeeding Bonanni as senior vice president of manufacturing will be Madhu Balachandran, who was previously vice president of operations at Amgen Manufacturing in Juncos, Puerto Rico. Amgen is headquartered in Thousand Oaks, Calif.

 

 

 

The Virginia Biotechnology Association has added two new members to its staff, raising the size of its workforce to five people. Stephanie Jenks has been named VaBIO’s new manager of membership and communications, while Dawn Freeman has joined the association as senior administrative assistant.

 

Jenks, who relocated from Syracuse, NY, previously served as assistant director of alumni and parent programs at her alma mater, Le Moyne College. While at Le Moyne, Jenks oversaw creation of regional alumni clubs as well as communications for targeted groups, and worked with various committees and sub-groups of the college’s board of trustees. Earlier she worked for the development arm of Hospice and Palliative Care in New Hartford, NY, where she planned fundraising events, supervised volunteers and coordinated marketing and publicity efforts.

 

Freeman spent the last six years as the former administrative assistant, development associate and special events manager for the Richmond (Va.) Symphony Orchestra. Previously, she worked as a benefits specialist and claims adjuster for United Healthcare and Sentry Insurance. Outside of her job, she runs her own catering business and is a licensed minister at the First Baptist Church in Richmond.

 

 

 

Sandra Fujiyama has been named a partner in the Los Angeles office of the law firm Sidley Austin, one of 36 new partners announced by the law firm on July 30. Fujiyama provides intellectual property counseling to biotechnology and medical clients in the firm’s intellectual property litigation practice, which focuses predominantly on complex patent litigation.

 

Fujiyama received her JD from the University of California at Los Angeles School of Law, where she was associate editor of the Pacific Basin Law Journal. She graduated summa cum laude from UCLA with a BSc in biochemistry.

 

 

 

Trevor Chaplick has joined Proskauer Rose as a partner in the law firm’s corporate department and co-head of the firm’s Washington, DC, office.

 

Chaplick has represented numerous biotechnology companies as well as communications, e-commerce, entertainment, Internet, media and software businesses in raising venture capital and other private financing from institutional investors.

 

Chaplick was previously managing partner of the Washington office of Wilson Sonsini Goodrich and Rosati, a law firm he founded. Earlier, he practiced at the San Francisco law firm Latham and Watkins, and worked in the financial services group of Arthur Andersen in Washington. He is a graduate of the University of Virginia School of Law, and the McIntire School of Commerce at the University of Virginia.

 

 

 

Kenneth Rind has been named a senior advisor at Caris & Company, where he will focus on the capital needs of the biotechnology and health care community from the investment bank's San Diego headquarters and New York office. Rind will also play a key role in developing Caris' international growth strategy.

 

Previously, Rind had been an investment banking/venture capital partner at CIBC predecessor Oppenheimer, a corporate development executive/strategic investor at Xerox, an advisor on public and private technology investments to the Rockefeller family, the portfolio manager of Samson Fund, a mutual fund focused on technology; and a founder of eight venture capital funds.

 

He currently serves on the boards of the US Civilian Research and Development Foundation, which grants cooperative funding to scientists and engineers in the former Soviet Union and beyond; the U.S.-Israel Science and Technology Foundation, jointly funded by the US and Israeli governments to foster international technology collaboration; and the Venture Investors

Association of New York.

 

 

 

Michael Prakken has been named manager of the Boston office of CBRE | Melody, the debt and equity placement division of CB Richard Ellis.

 

Since joining CBRE Melody in 2000, Prakken has originated more than $1 billion in new mortgage debt through development loans, mezzanine loans, participating debt, as well as conventional fixed-rate loans.

 

With offices in Boston and Hartford, Conn., CBRE Melody's New England operation last year generated $20.8 billion in real estate financing transactions, and currently maintains a servicing portfolio of more than 8,600 loans totaling approximately $94 billion through an affiliate, GEMSA Loan Services.

 

Before joining the firm, Prakken was a senior vice president in the commercial real estate division of Fleet Bank, since merged into Bank of America. Previously he served as a senior vice president and divisional manger with the Bank of New England. Prakken is a member of the Greater Boston Real Estate Board and the Real Estate Finance Association.